tiprankstipranks
Sinopharm Group Co (DE:X2S1)
FRANKFURT:X2S1
Germany Market

Sinopharm Group Co (X2S1) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

X2S1 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

X2S1 Stock 12 Month Forecast

There Are No Analyst Ratings for DE:X2S1 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

X2S1 Financial Forecast

X2S1 Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

X2S1 Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:X2S1
TipRanks - xAI
TipRanks - xAI
€9.58
Hold
-13.66%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:X2S1
TipRanks - DeepSeek
TipRanks - DeepSeek
€9.15
Hold
-17.59%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:X2S1
TipRanks - PerPlexity
TipRanks - PerPlexity
€9.58
Hold
-13.66%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:X2S1
TipRanks - Anthropic
TipRanks - Anthropic
€9.15
Hold
-17.59%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:X2S1
TipRanks - Google
TipRanks - Google
€9.58
Hold
-13.66%
Downside
Downgraded
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:X2S1
TipRanks - OpenAI
TipRanks - OpenAI
€9.58
Hold
-13.66%
Downside
Downgraded
06/21/26
AI Generated ArticleAI Generated Article
Analyst Type
Any
Any
AI Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks - xAI Analyst forecast on DE:X2S1
TipRanks - xAI
TipRanks - xAI
€9.58
Hold
-13.66%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - DeepSeek Analyst forecast on DE:X2S1
TipRanks - DeepSeek
TipRanks - DeepSeek
€9.15
Hold
-17.59%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - PerPlexity Analyst forecast on DE:X2S1
TipRanks - PerPlexity
TipRanks - PerPlexity
€9.58
Hold
-13.66%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - Anthropic Analyst forecast on DE:X2S1
TipRanks - Anthropic
TipRanks - Anthropic
€9.15
Hold
-17.59%
Downside
Reiterated
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - Google Analyst forecast on DE:X2S1
TipRanks - Google
TipRanks - Google
€9.58
Hold
-13.66%
Downside
Downgraded
06/21/26
AI Generated ArticleAI Generated Article
TipRanks - OpenAI Analyst forecast on DE:X2S1
TipRanks - OpenAI
TipRanks - OpenAI
€9.58
Hold
-13.66%
Downside
Downgraded
06/21/26
AI Generated ArticleAI Generated Article
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

X2S1 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, X2S1 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. X2S1 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

X2S1 Stock Forecast FAQ

What is DE:X2S1’s average 12-month price target, according to analysts?
Currently, no data Available
What is DE:X2S1’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for DE:X2S1, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sinopharm Group Co a Buy, Sell or Hold?
      Currently, no data Available
      What is Sinopharm Group Co’s share price target?
      Currently, no data Available
      What do analysts say about Sinopharm Group Co?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sinopharm Group Co?
      To buy shares of DE:X2S1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.